| 出品公司: | ATCC |
|---|---|
| 菌种名称: | ATCC49938, ATCC 49938 |
| 菌种又名: | MF 614 [DSM 44680, W 6743] |
| 菌株类型: | 布里斯班分枝杆菌Mycobacterium brisbanense |
| 存储人: | RJ Wallace |
| 分离来源: | 组织，人类，布里斯班澳大利亚 |
| 产品目录号: | 49938 |
| 培养基: | ATCC®培养基18：胰蛋白酶大豆琼脂/肉汤 |
| 生长条件: | 35 ℃, 有氧 |
| 生物安全等级: | 2 |
| 模式菌株: | 是 |
| 菌株特点: |
ATCC49938 布里斯班分枝杆菌Mycobacterium brisbanense |
| 参考文献: |
Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732
Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
antral sinus, Brisbane, Australia
Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
|
| MF 614 [DSM 44680, W 6743] |
